Ropes Wealth Advisors LLC Gilead Sciences, Inc. Transaction History

Ropes Wealth Advisors LLC

$512 Million
Q3 2023

A detailed history of Ropes Wealth Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Ropes Wealth Advisors LLC holds 2,720 shares of GILD stock, worth $239,577. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,720

Previous 3,224 15.63%

Holding current value

$239,577

Previous $248,000 18.15%

% of portfolio

0.04%

Previous 0.04%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 19, 2023	SELL	$73.94 - $80.67 $37,265 - $40,657	-504 Reduced 15.63%	2,720 $203,000
Q2 2023 Aug 07, 2023	BUY	$76.01 - $86.7 $26,527 - $30,258	349 Added 12.14%	3,224 $248,000
Q1 2023 May 08, 2023	SELL	$77.31 - $88.08 $37,186 - $42,366	-481 Reduced 14.33%	2,875 $238,000
Q4 2022 Feb 06, 2023	BUY	$62.32 - $89.47 $209,145 - $300,261	3,356 New	3,356 $288,000
Q2 2022 Aug 10, 2022	SELL	$57.72 - $65.01 $229,610 - $258,609	-3,978 Closed	0 $0
Q1 2022 May 04, 2022	SELL	$57.92 - $72.58 $82,651 - $103,571	-1,427 Reduced 26.4%	3,978 $236,000
Q4 2021 Feb 10, 2022	BUY	$64.88 - $73.64 $94,530 - $107,293	1,457 Added 36.9%	5,405 $392,000
Q3 2021 Nov 05, 2021	SELL	$67.69 - $73.03 $11,710 - $12,634	-173 Reduced 4.2%	3,948 $276,000
Q1 2021 May 12, 2021	SELL	$60.0 - $68.46 $323,880 - $369,547	-5,398 Reduced 56.71%	4,121 $277,000
Q4 2020 Feb 05, 2021	SELL	$56.65 - $64.55 $198,841 - $226,570	-3,510 Reduced 26.94%	9,519 $555,000
Q3 2020 Oct 16, 2020	SELL	$62.1 - $78.08 $8,880 - $11,165	-143 Reduced 1.09%	13,029 $823,000
Q2 2020 Jul 20, 2020	SELL	$72.34 - $84.0 $201,466 - $233,940	-2,785 Reduced 17.45%	13,172 $1.01 Million
Q1 2020 Apr 24, 2020	BUY	$62.63 - $80.22 $559,348 - $716,444	8,931 Added 127.11%	15,957 $1.19 Million
Q4 2019 Feb 05, 2020	SELL	$61.62 - $67.78 $784,977 - $863,449	-12,739 Reduced 64.45%	7,026 $457,000
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $120,831 - $133,377	1,933 Added 10.84%	19,765 $1.25 Million
Q2 2019 Jul 31, 2019	BUY	$61.87 - $69.38 $5,815 - $6,521	94 Added 0.53%	17,832 $1.21 Million
Q1 2019 Apr 15, 2019	SELL	$62.53 - $70.05 $18,008 - $20,174	-288 Reduced 1.6%	17,738 $1.15 Million
Q4 2018 Feb 08, 2019	SELL	$60.54 - $79.0 $86,572 - $112,970	-1,430 Reduced 7.35%	18,026 $1.13 Million
Q3 2018 Oct 30, 2018	SELL	$71.28 - $78.92 $18,033 - $19,966	-253 Reduced 1.28%	19,456 $1.5 Million
Q1 2018 Apr 30, 2018	SELL	$72.84 - $88.8 $30,957 - $37,740	-425 Reduced 2.11%	19,709 $1.49 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $249,096 - $292,403	3,501 Added 21.05%	20,134 $1.44 Million
Q3 2017 Nov 09, 2017	BUY	$72.11 - $85.47 $1.2 Million - $1.42 Million	16,633	16,633 $1.35 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ropes Wealth Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ropes Wealth Advisors LLC with notifications on news.

Account

Ropes Wealth Advisors LLC Gilead Sciences, Inc. Transaction History